Results 111 to 120 of about 490,601 (215)
International audienceSelected diffuse malignant peritoneal mesothelioma (DMPM) patients may be radically treated with complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Goéré, Diane +104 more
core +1 more source
Surgical staging procedures are used to select patients with peritoneal metastases for surgery. We aimed to evaluate the impact of surgical staging procedures and the risk of abdominal wall recurrences in patients with peritoneal metastases scheduled for
Ghanipour Lana +3 more
doaj +1 more source
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is used to treat peritoneal surface malignancies. However, surgical morbidity is high, and prediction of severe postoperative complications (SPC) is limited.
Goder Noam +8 more
doaj +1 more source
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Daniel L Chan, David L Morris, Archana Rao, Terence C ChuaHepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, and the St George Clinical School, University of New South Wales, St George Hospital, Kogarah, NSW, AustraliaPurpose: To ...
Chua TC, Rao A, Morris DL, Chan DL
doaj
Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience. [PDF]
Neveu J +4 more
europepmc +1 more source
Background: Peritoneal metastasis represents an aggressive disease pattern in pancreatic ductal adenocarcinoma (PDAC), traditionally associated with poor survival and limited therapeutic options.
Hani M. Babiker +17 more
core +1 more source
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment for selected patients with colorectal peritoneal metastases (CPM).
Brindl Niall +6 more
doaj +1 more source
Comment on 'Effect of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on survival and recurrence rates in advanced gastric cancer - a systematic review and meta-analysis'. [PDF]
Liang XW, Liu H, Wu JC.
europepmc +1 more source
Conversion Therapy for Gastric Cancer with Peritoneal Metastasis
Peritoneal metastasis in gastric cancer has a poor prognosis and is increasing in prevalence. Neoadjuvant chemotherapy is used for advanced tumors; however, surgery is generally not considered for metastatic and unresectable diseases.
Thita Intralawan +9 more
doaj
The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer. [PDF]
Sun BJ, Daniel SK, Lee B.
europepmc +1 more source

